Rebecca E Chandler

14PUBLICATIONS
39CO-AUTHORS
Disease surveillanceDevelopment cooperationInformation systems for sustainable development and the public goodToxicology (incl. clinical toxicology)Pharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 27, 2025
Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries.

Andy Stergachis, Esperança Sevene, Mohammad Gazi Shah Alam

|Aug 21, 2024
Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.

Suneth Agampodi, Ondari D Mogeni, Rebecca Chandler

|Mar 07, 2024
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group.

Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur

|Apr 29, 2022
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.

Rani Lill Anjum, Rebecca E Chandler, Elena Rocca

|Jan 12, 2022
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports.

Corine Ekhart, Florence van Hunsel, Eugène van Puijenbroek

|Apr 10, 2021
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.

Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki

Pageof 3

Frequent Collaborators

2 joint publications

Henric Taavola

2 joint publications

Yasunori Aoki

2 joint publications

G Niklas Norén

1 joint publications

Lovisa Sandberg